Greetings from MyCancerHaven!
We wanted to update you on our recent activities.
Here are the latest posts last week:
Blogs :
Dr. Winter explains treatment history’s role in Richter Transformation development.
Dr. Bhat discusses BTK degraders and bispecific antibodies for R/R CLL.
Dr. Bhat discusses the limitations of current therapies for double-refractory CLL.
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCHFollow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
We wanted to update you on our recent activities.
Here are the latest posts last week:
Blogs :
Dr. Winter explains treatment history’s role in Richter Transformation development.
Dr. Bhat discusses BTK degraders and bispecific antibodies for R/R CLL.
Dr. Bhat discusses the limitations of current therapies for double-refractory CLL.
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCHFollow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
